{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:38:09Z","timestamp":1790973489092,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"crossref","award":["PSAU\/2025\/R\/1446"],"award-info":[{"award-number":["PSAU\/2025\/R\/1446"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02773-7","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:23:24Z","timestamp":1748427804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug repurposing targeting COVID-19 3CL protease using molecular docking and machine learning regression approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Imra","family":"Aqeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Majid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Albanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Wasfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"2773_CR1","doi-asserted-by":"publisher","unstructured":"Su, Y. et al. A network-based drug target set enrichment analysis method for drug repurposing against COVID-19. Comput. Biol. Med. 106969 https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106969 (2023).","DOI":"10.1016\/j.compbiomed.2023.106969"},{"key":"2773_CR2","doi-asserted-by":"publisher","first-page":"117652","DOI":"10.1016\/j.lfs.2020.117652","volume":"252","author":"B Shah","year":"2020","unstructured":"Shah, B., Modi, P. & Sagar, S. R. In Silico studies on therapeutic agents for COVID-19: drug repurposing approach. Life Sci. 252, 117652 (2020).","journal-title":"Life Sci."},{"key":"2773_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"2773_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-biodatasci-110123-025333","volume":"7","author":"HC Cousins","year":"2024","unstructured":"Cousins, H. C., Nayar, G. & Altman, R. B. Computational approaches to drug repurposing: methods, challenges, and opportunities. Annual Rev. Biomedical Data Sci. 7, 15\u201329 (2024).","journal-title":"Annual Rev. Biomedical Data Sci."},{"key":"2773_CR5","unstructured":"Eur, K. et al. Identification of SARS-CoV-2 main protease inhibitors using chemical similarity analysis combined with machine learning. 2, (2024)."},{"key":"2773_CR6","doi-asserted-by":"publisher","unstructured":"Wang, Y., Gao, Q., Yao, P., Yao, Q. & Zhang, J. Multidimensional virtual screening approaches combined with drug repurposing to identify potential covalent inhibitors of SARS-CoV-2 3CL protease. J. Biomol. Struct. Dynamics. 1\u201324. https:\/\/doi.org\/10.1080\/07391102.2023.2193994 (2023).","DOI":"10.1080\/07391102.2023.2193994"},{"key":"2773_CR7","first-page":"683","volume":"3","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis. Lancet 3, 683\u2013692 (2022).","journal-title":"Lancet"},{"key":"2773_CR8","doi-asserted-by":"publisher","first-page":"578148","DOI":"10.1016\/j.jneuroim.2023.578148","volume":"381","author":"A Medina","year":"2023","unstructured":"Medina, A. et al. Treatment with Sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques. J. Neuroimmunol. 381, 578148 (2023).","journal-title":"J. Neuroimmunol."},{"key":"2773_CR9","first-page":"1","volume":"18","author":"N Khan","year":"2023","unstructured":"Khan, N., Muzammil, K. & Alshahrani, A. M. In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease. PloS One. 18, 1\u201327 (2023).","journal-title":"PloS One"},{"key":"2773_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/ph15111333","volume":"15","author":"I Aqeel","year":"2022","unstructured":"Aqeel, I., Bilal, M., Majid, A. & Majid, T. Hybrid approach to identifying druglikeness leading compounds against COVID-19 3CL protease. Pharmaceuticals 15, 1333 (2022).","journal-title":"Pharmaceuticals"},{"key":"2773_CR11","first-page":"2980","volume":"39","author":"EA D","year":"2020","unstructured":"D, E. A., Anas, A., Tegin, \u015e. A. & Kemal, Y. Drug repurposing for coronavirus (COVID-19): in Silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dynamics. 39, 2980\u20132992 (2020).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"2773_CR12","doi-asserted-by":"crossref","unstructured":"Jha, N. et al. Deep Learning Approach for Discovery of in Silico Drugs for Combating COVID-19. Journal of Healthcare Engineering 1\u201313 (2021). (2021).","DOI":"10.1155\/2021\/6668985"},{"key":"2773_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c00030","author":"N Ghosh","year":"2023","unstructured":"Ghosh, N., Saha, I. & Gambin, A. Interactome-Based machine learning predicts potential therapeutics for COVID-19. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.3c00030 (2023).","journal-title":"ACS Omega"},{"key":"2773_CR14","first-page":"1","volume":"00","author":"A Khan","year":"2023","unstructured":"Khan, A., Khan, S. H., Saif, M., Batool, A. & Khan, M. W. A survey of deep learning techniques for the analysis of COVID-19 and their usability for detecting Omicron A survey of deep learning techniques for the analysis of ABSTRACT. J. Exp. Theor. Artif. Intell. 00, 1\u201343 (2023).","journal-title":"J. Exp. Theor. Artif. Intell."},{"key":"2773_CR15","doi-asserted-by":"publisher","first-page":"105992","DOI":"10.1016\/j.compbiomed.2022.105992","volume":"150","author":"S Doshi","year":"2022","unstructured":"Doshi, S. & Chepuri, S. P. A computational approach to drug repurposing using graph neural networks. Comput. Biol. Med. 150, 105992 (2022).","journal-title":"Comput. Biol. Med."},{"key":"2773_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. Software news and update AutoDock Vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"2773_CR17","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"Yap","year":"2011","unstructured":"Yap & Wei, C. 16_J comput chem \u2013\u20092010 - Yap - PaDEL-descriptor an open source software to calculate molecular descriptors and fingerprints.pdf. J. Comput. Chem. 32, 1466\u20131474 (2011).","journal-title":"J. Comput. Chem."},{"key":"2773_CR18","doi-asserted-by":"publisher","unstructured":"Ahmed, A., Abdusalam, A. & Murugaiyah, V. Identification of potential inhibitors of 3CL protease of SARS-CoV-2 from ZINC database by molecular Docking-Based virtual screening. Front. Mol. Biosci. 419 https:\/\/doi.org\/10.3389\/fmolb.2020.603037 (2020).","DOI":"10.3389\/fmolb.2020.603037"},{"key":"2773_CR19","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","volume":"60","author":"JJ Irwin","year":"2020","unstructured":"Irwin, J. J. et al. ZINC20\u2014A free Ultralarge-Scale chemical database for ligand discovery. J. Chem. Inf. Model. 60, 6065\u20136073 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"2773_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NMO Boyle","year":"2011","unstructured":"Boyle, N. M. O. et al. Open babel: an open chemical toolbox. J. Cheminform. 3, 1\u201314 (2011).","journal-title":"J. Cheminform."},{"key":"2773_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2017.07.185","volume":"106","author":"T Ilm","year":"2018","unstructured":"Ilm, T. et al. International journal of biological macromolecules A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and Inhibition of protein aggregates : an overview. Int. J. Biol. Macromol. 106, 1115\u20131129 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"2773_CR22","doi-asserted-by":"publisher","first-page":"101319","DOI":"10.1016\/j.rechem.2024.101319","volume":"7","author":"A Sarkar","year":"2024","unstructured":"Sarkar, A., Concilio, S., Sessa, L., Marrafino, F. & Piotto, S. Results in chemistry advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular Docking. Results Chem. 7, 101319 (2024).","journal-title":"Results Chem."},{"key":"2773_CR23","doi-asserted-by":"crossref","unstructured":"Simeon, S. et al. Probing the origins of human acetylcholinesterase Inhibition via QSAR modeling and molecular Docking. PeerJ 4, (2016).","DOI":"10.7717\/peerj.2322"},{"key":"2773_CR24","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.3390\/ijms26062680","volume":"26","author":"S Atasever","year":"2025","unstructured":"Atasever, S. & Enhancing HCV NS3 inhibitor classification with optimized molecular fingerprints using random forest. Int. J. Mol. Sci. 26, 2680 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"2773_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/ph13120431","volume":"13","author":"B Suay-garcia","year":"2020","unstructured":"Suay-garcia, B. et al. Tree-Based QSAR model for drug repurposing in the discovery of new antibacterial compounds against Escherichia coli. Pharmaceuticals 13, 431 (2020).","journal-title":"Pharmaceuticals"},{"key":"2773_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1016409317640","volume":"26","author":"V Podgorelec","year":"2002","unstructured":"Podgorelec, V., Kokol, P., Stiglic, B. & Rozman, I. Decision trees: an overview and their use in medicine. J. Med. Syst. 26, 445\u2013463 (2002).","journal-title":"J. Med. Syst."},{"key":"2773_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.inffus.2015.06.005","volume":"27","author":"L Rokach","year":"2016","unstructured":"Rokach, L. Decision forest: Twenty years of research. Inform. FUSION. 27, 111\u2013125 (2016).","journal-title":"Inform. FUSION"},{"key":"2773_CR28","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41467-024-46296-7","volume":"15","author":"D Lee","year":"2024","unstructured":"Lee, D. et al. Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2. Nat. Commun. 15, 2108 (2024).","journal-title":"Nat. Commun."},{"key":"2773_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/biom14070797","volume":"14","author":"A Zag","year":"2024","unstructured":"Zag, A., Czopek, A., Fryc, M. & Jo, J. Inhibitors of SARS-CoV-2 main protease (Mpro) as Anti-Coronavirus agents. Biomolecules 14, 797 (2024).","journal-title":"Biomolecules"},{"key":"2773_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5599\/admet.1022","volume":"9","author":"A Tsantili-kakoulidou","year":"2021","unstructured":"Tsantili-kakoulidou, A. & Demopoulos, V. J. Drug-like properties and fraction lipophilicity index as a combined metric. ADMET DMPK. 9, 177\u2013190 (2021).","journal-title":"ADMET DMPK"},{"key":"2773_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings i. Adv. Drug Deliv. Rev. 64, 4\u201317 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2773_CR32","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1021\/acs.jmedchem.1c00416","volume":"64","author":"PD Leeson","year":"2021","unstructured":"Leeson, P. D. et al. Europe PMC funders group Target-based evaluation of \u2018 drug-like \u2019 properties and ligand efficiencies. J. Med. Chem. 64, 7210\u20137230 (2021).","journal-title":"J. Med. Chem."},{"key":"2773_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/v17030404","volume":"17","author":"M Andreescu","year":"2025","unstructured":"Andreescu, M., Niculet, E., Plesea-condratovici, A. & Arbune, M. Managing HIV-Associated hodgkin lymphoma during the COVID-19 pandemic: case report and literature review. Viruses 17, 404 (2025).","journal-title":"Viruses"},{"key":"2773_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41401-024-01382-w","volume":"46","author":"E Chen","year":"2024","unstructured":"Chen, E. & Xi, L. Cardiovascular adverse effects of antiviral therapies for COVID-19: evidence and plausible mechanisms. Acta Pharmacol. Sin. 46, 554\u2013564 (2024).","journal-title":"Acta Pharmacol. Sin."},{"key":"2773_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13619-024-00201-1","volume":"13","author":"Y Yu","year":"2024","unstructured":"Yu, Y. et al. Targeting senescent cells in aging and COVID \u2013 19: from cellular mechanisms to therapeutic opportunities. Cell. Regeneration. 13, 20 (2024).","journal-title":"Cell. Regeneration"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02773-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:23:27Z","timestamp":1748427807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02773-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2773"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02773-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18722"}}